OOIR: Observatory of International Research

Papers

(The H4-Index of Current Opinion in Virology is 31. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-11-01 to 2024-11-01.)

Article	Citations
Structure of SARS-CoV-2 spike protein	150
Developing a direct acting, orally available antiviral agent in a pandemic: the evolution of molnupiravir as a potential treatment for COVID-19	128
Considerations for the discovery and development of 3-chymotrypsin-like cysteine protease inhibitors targeting SARS-CoV-2 infection	106
Current challenges to virus discovery by meta-transcriptomics	68
Future considerations for the mRNA-lipid nanoparticle vaccine platform	66
Zoonotic disease and virome diversity in bats	63
Global overview and major challenges of host prediction methods for uncultivated phages	62
Structure and function of SARS-CoV-2 polymerase	57
The virome of vector mosquitoes	57
Coronavirus entry: how we arrived at SARS-CoV-2	57
RNA viruses and the cGAS-STING pathway: reframing our understanding of innate immune sensing	55
A structural view of the SARS-CoV-2 virus and its assembly	55
Animal models for SARS-CoV-2	54
The healthy human virome: from virus–host symbiosis to disease	51
Engineering therapeutic phages for enhanced antibacterial efficacy	50
Structure, function and assembly of the long, flexible tail of siphophages	46
Recent advances in understanding plant antiviral RNAi and viral suppressors of RNAi	46
Cell-to-cell movement of plant viruses via plasmodesmata: a current perspective on potyviruses	44
Viral Z-RNA triggers ZBP1-dependent cell death	44
Anti-viral protective capacity of tissue resident memory T cells	40
European regulatory aspects of phage therapy: magistral phage preparations	40
COVID-19, the first pandemic in the post-genomic era	40
Perspective on taxonomic classification of uncultivated viruses	38
Interfering with SARS-CoV-2: are interferons friends or foes in COVID-19?	37
Host cell-intrinsic innate immune recognition of SARS-CoV-2	37

Entry of influenza A virus into host cells — recent progress and remaining challenges	36
Tombusviruses orchestrate the host endomembrane system to create elaborate membranous replication organelles	35
Mitigation of evolved bacterial resistance to phage therapy	34
Viral structural proteins as targets for antivirals	32
Phage banks as potential tools to rapidly and cost-effectively manage antimicrobial resistance in the developing world	32
Detection of viruses by inflammasomes	31